An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: apparent evidence of effective enhancement without tissue damage
- 1 January 1994
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 101 (1-2) , 15-22
- https://doi.org/10.1016/0378-5173(94)90071-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Drug Delivery via the Mucous Membranes of the Oral CavityJournal of Pharmaceutical Sciences, 1992
- Nasal Absorption Enhancers for Biosynthetic Human Growth Hormone in RatsPharmaceutical Research, 1990
- Comparison of the effects of various transmucosal absorption promoters on buccal insulin deliveryInternational Journal of Pharmaceutics, 1989
- Kinetics and dynamics of nifedipine after oral and sublingual dosesThe American Journal of Medicine, 1986
- “PATIENT DEMAND” POSTOPERATIVE ANALGESIA WITH BUPRENORPHINEBritish Journal of Anaesthesia, 1986
- Adhesive topical drug delivery systemJournal of Controlled Release, 1985
- BUCCAL MORPHINE—A NEW ROUTE FOR ANALGESIA?The Lancet, 1985
- Effect of enzyme digestion on the permeability barrier in keratinizing and non-keratinizing epitheliaBritish Journal of Dermatology, 1984
- New mucosal dosage form of insulin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981
- In vitro penetration of tritiated dextrans through rabbit oral mucosaArchives of Oral Biology, 1975